Three Seasons Wealth LLC Takes Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Three Seasons Wealth LLC bought a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund bought 1,352 shares of the biotechnology company's stock, valued at approximately $804,000.

A number of other institutional investors have also recently made changes to their positions in AXON. New Wave Wealth Advisors LLC acquired a new position in shares of Axon Enterprise in the fourth quarter worth approximately $40,000. Y.D. More Investments Ltd acquired a new position in shares of Axon Enterprise in the fourth quarter worth approximately $45,000. Stonebridge Financial Group LLC bought a new stake in Axon Enterprise in the fourth quarter worth approximately $53,000. GPS Wealth Strategies Group LLC increased its holdings in Axon Enterprise by 74.1% in the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock worth $56,000 after purchasing an additional 40 shares in the last quarter. Finally, Versant Capital Management Inc increased its holdings in Axon Enterprise by 4,750.0% in the fourth quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company's stock worth $58,000 after purchasing an additional 95 shares in the last quarter. Institutional investors own 79.08% of the company's stock.

Insiders Place Their Bets

In other news, CEO Patrick W. Smith sold 10,000 shares of the company's stock in a transaction on Monday, April 21st. The stock was sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the transaction, the chief executive officer now owns 3,063,982 shares of the company's stock, valued at $1,657,583,622.18. This represents a 0.33 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jeri Williams sold 307 shares of the company's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now directly owns 1,627 shares in the company, valued at $899,275.44. This represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. Insiders own 6.10% of the company's stock.

Axon Enterprise Stock Performance

AXON stock traded down $5.99 during midday trading on Wednesday, hitting $605.14. The company's stock had a trading volume of 167,478 shares, compared to its average volume of 760,929. The stock's 50-day moving average price is $547.11 and its 200 day moving average price is $574.11. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $715.99. The stock has a market cap of $47.11 billion, a price-to-earnings ratio of 156.37, a PEG ratio of 5.17 and a beta of 1.13.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on AXON shares. TD Cowen began coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 target price for the company. Northcoast Research downgraded Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. Craig Hallum downgraded Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Barclays restated a "hold" rating on shares of Axon Enterprise in a report on Monday, March 10th. Finally, The Goldman Sachs Group boosted their price objective on Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $626.45.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.